Marco Herrera

Marco Herrera’s research focuses on the intersection of non-viral delivery systems and cell therapy applications for treating hematological malignancies. His current work utilizes lipid nanoparticles to deliver mRNAs to T cells, specifically targeting acute myeloid leukemia (AML). Additionally, he is developing logic-gated CAR T cells to enhance AML therapy. Marco earned his Bachelor of Science in Molecular Biology from UC Davis and completed his doctoral training at Oregon State University, where he specialized in developing lipid nanoparticles for gene delivery applications. Marco is also deeply committed to mentoring undergraduates, both in the laboratory and through academic guidance. In his spare time, he volunteers with local astronomy clubs, participating in outreach programs that bring science to schools and engage with children and their families. Outside of his professional endeavors, Marco enjoys spending quality time with family and friends by going on hikes or visiting the local farmers market on the weekends.